Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alice Yu

Showing results (101-110 of 105) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 105 results.
Cancer Medicine|July 7, 2022
Identifying and overcoming barriers to participation of minority populations in clinical trials: Lessons learned from the VanDAAM studyAngelina K C Fink, Amanda C DeRenzis, Shivanshu Awasthi, et al.
Cancers|June 27, 2024
A Description and Safety Overview of Irreversible Electroporation for Prostate Tissue Ablation in Intermediate-Risk Prostate Cancer Patients: Preliminary Results from the PRESERVE TrialArvin K George, Ranko Miocinovic, Amit R Patel, et al.
Clinical Genitourinary Cancer|October 1, 2024
A Single Institution Experience in the Management of Localized Neuroendocrine Carcinoma of the BladderCasey Liveringhouse, Austin J Sim, Jingsong Zhang, et al.
European Urology|July 20, 2025
Irreversible Electroporation for Prostate Tissue Ablation in Patients with Intermediate-risk Prostate Cancer: Results from the PRESERVE TrialArvin K George, Ranko Miocinovic, Amit R Patel, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 10, 2023
NCCN Guidelines® Insights: Prostate Cancer Early Detection, Version 1.2023Kelvin A Moses, Preston C Sprenkle, Clinton Bahler, et al.
Pageof 11

Showing results (101-110 of 105) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 105 results.
Cancer Medicine|July 7, 2022
Identifying and overcoming barriers to participation of minority populations in clinical trials: Lessons learned from the VanDAAM studyAngelina K C Fink, Amanda C DeRenzis, Shivanshu Awasthi, et al.
Cancers|June 27, 2024
A Description and Safety Overview of Irreversible Electroporation for Prostate Tissue Ablation in Intermediate-Risk Prostate Cancer Patients: Preliminary Results from the PRESERVE TrialArvin K George, Ranko Miocinovic, Amit R Patel, et al.
Clinical Genitourinary Cancer|October 1, 2024
A Single Institution Experience in the Management of Localized Neuroendocrine Carcinoma of the BladderCasey Liveringhouse, Austin J Sim, Jingsong Zhang, et al.
European Urology|July 20, 2025
Irreversible Electroporation for Prostate Tissue Ablation in Patients with Intermediate-risk Prostate Cancer: Results from the PRESERVE TrialArvin K George, Ranko Miocinovic, Amit R Patel, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 10, 2023
NCCN Guidelines® Insights: Prostate Cancer Early Detection, Version 1.2023Kelvin A Moses, Preston C Sprenkle, Clinton Bahler, et al.
Pageof 11